Premium
O3‐06‐02: Toll‐like receptor 9 ligand CpG ODN as a new highly effective agent for prevention and/or treatment of Alzheimer's disease
Author(s) -
Scholtzova Henrieta,
Kascsak Richard J.,
Bates Kristyn A.,
Boutajangout Allal,
Kerr Daniel J.,
Meeker Harry C.,
Mehta Pankaj D.,
Spinner Daryl S.,
Wisniewski Thomas
Publication year - 2009
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2009.05.467
Subject(s) - tlr9 , agonist , immune system , innate immune system , medicine , stimulation , immunology , toll like receptor 9 , genetically modified mouse , receptor , pharmacology , toxicity , toll like receptor , biology , transgene , biochemistry , gene expression , gene , dna methylation